Skip to content

SION SION Restricted Cash

Restricted Cash at other companies

Septerna, Inc. logo
Septerna, Inc.SEPN
$905K0.0%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$854K+193%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$3.1M0.0%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's restricted cash?
SION (SION) reported restricted cash of $963K in Q1 2026.
How has SION's restricted cash changed year-over-year?
SION's restricted cash increased by 0.1% year-over-year, from $962K to $963K.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.